CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus launches affordable oral anti-diabetic tablet Vinglyn11-12-2019
11-12-2019
CADILA HEALTHCARE LTD. - 532321 - Consolidated Related Party Transactions Half Year Ended On September 30, 2019
Consolidated Related Party Transactions Half Year ended on September 30, 201907-12-2019
Cadila Healthcare Ltd - 532321 - Announcement
Inspection by US FDA of company''s API manufacturing facility located at Dabhasa, Gujarat and company received an Establishment Inspection Report (EIR) which stated that the classification of the facility is "No Action Indicated (NAI)".06-12-2019
Cadila Healthcare files NDA with DCGI for liver disease drug Saroglitazar Mg
If the latest NDA is approved, Saroglitazar Mg could become the first medicine indicated for the treatment of Non-alcoholic Steatohepatitis (NASH).05-12-2019
Cadila Healthcare Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus announces regulatory filing of Saroglitazar Magnesium for treatment of NASH with DCGI05-12-2019
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives tentative approval from the USFDA for Lorcaserin Hydrochloride Tablets03-12-2019
Cadila Healthcare gets board nod for amalgamation
Scheme of amalgamation cleared for four wholly-owned subsidiaries with parent02-12-2019
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Meeting Updates
Amalgamation of four wholly owned subsidiary companies02-12-2019
CADILA HEALTHCARE LTD. - 532321 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificate / issue of duplicate share certificate under regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations)28-11-2019
Cadila Healthcare
Cadila Healthcare said it has received approval from the US health regulator to market Isosorbide Dinitrate tablets used to prevent attacks of chest p21-11-2019